iVascular Receives CE Mark Approval for the Navitian Coronary Microcatheter

 

February 15, 2019—iVascular announced that it has received European CE Mark approval for Navitian, the company’s new coronary microcatheter specifically designed for navigating chronic total occlusions.

The device is approved to exchange guidewires, inject radiopaque contrast media or saline, and facilitate, guide, and support guidewires while accessing the coronary system.

According to the company, key features of the Navitian device include:

  • Internal and external conical transition
  • A braided pattern for flexibility, pushability, and resistance to kinking
  • Hydrophilic coating to track small and tortuous arteries
  • An internal polytetrafluoroethylene-layer for facilitating guidewire movement during exchange
  • 135- and 150-cm sizes and 0.014-inch guidewire compatibility
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.